Congers, NY, United States of America

Ronald Stanley Michalak

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Wyeth, Genaera Corporation, Ohr Pharmaceutical Inc.. Active years: 2005-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald Stanley Michalak. Retrieved from https://idiyas.com/inventor/ronald-stanley-michalak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 30.8

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Ronald Stanley Michalak

Introduction

Ronald Stanley Michalak is a notable inventor based in Congers, NY (US). He holds a total of 13 patents, showcasing his significant contributions to the field of innovation. His work primarily focuses on the synthesis of chemical compounds that have applications in pharmaceuticals.

Latest Patents

Among his latest patents, Michalak has developed a compound of formula 1, which provides a novel approach to synthesizing sulfonyl halides and sulfonamides from sulfonic acid salts. These synthetic processes are crucial for the preparation of intermediates used in pharmaceutical development.

Career Highlights

Throughout his career, Michalak has worked with prominent companies such as Wyeth and Ohr Pharmaceutical Inc. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Some of his notable coworkers include Panolil C Raveendranath and Christoph Martin Dehnhardt. Their collaborative efforts have likely enhanced the quality and impact of the inventions they worked on together.

Conclusion

Ronald Stanley Michalak's contributions to the field of innovation, particularly in the pharmaceutical sector, highlight his expertise and dedication as an inventor. His work continues to influence the development of important chemical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…